CGAAY yields 74.32% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, CGAAY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CGAAY + PFE for your $10,000?
A2B Australia Limited, together with its subsidiaries, provides technologies, payment, and taxi related services in Australia. The company operates through three segments: Mobility Services, Mobility Platforms, and Payments. Its mobility Services segment offers taxi networks services to taxi operators and drivers, taxi booking services, vehicle financing and insurance, and full taxi fit-outs and repairs, as well as driver training and education. The Mobility Platforms segment provides booking, payment, and dispatch technologies to mobility providers. Its Payments segment offers merchant acquiring, consulting, licensing, and other payment services. The company also provides courier services, hardware and car sales; school bus route services; and taxi equipment and rental services. The company sells its taxi network services under CAB CHARGE, Maxi Taxi and Yellow Couriers, Silver Service, 13cabs, MTI, Spotto, EFT solutions, and GIRAFFE PAYMENTS brands. A2B Australia Limited was founded in 1976 and is headquartered in Alexandria, Australia.
Full CGAAY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.